Definitive Healthcare Corp. — Form SCHEDULE 13D/A
Filed October 1, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 72/100
What the filing says
Advent International, L.P. entered into a confidentiality agreement with Definitive Healthcare Corp. dated September 29, 2026, to evaluate a potential negotiated transaction. The agreement includes a 12-month standstill provision restricting Advent from acquiring securities, seeking board representation, or soliciting employees; a 12-month employee non-solicitation period; and standard confidentiality and information-use restrictions. The standstill terminates early if a third party initiates a sale process exceeding 50% equity or any Fall-Away Event occurs. No specific transaction terms, pricing, or equity stake have been disclosed.
Why this rating
Material exploratory stage M&A activity; Advent is major global PE investor; outcome uncertain but confidentiality structure signals serious preliminary discussions. Standstill and restrictions are standard. No deal certainty or financial terms disclosed. Relative to $154M market cap, potential transformational if completed, but early-stage signaling limits near-term impact.
Price action (we called it neutral)
before filing · preread $0.94 | at our read pending | +10 min pending | +30 min pending | +1 hr pending | +4 hrs pending |
Quotes via Yahoo Finance at capture time; for filings arriving outside market hours the clock starts at the next open. Not investment advice. How accurate are our calls? →
See more from October 1, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.